glp 1 alzheimer's disease Could diabetes and weight loss drugs treat disease? GLP-1 improves the neuronal supportive
Description
Patients with inflammatory arthritis conditions should continue disease-modifying treatments as prescribed by their rheumatologist
This 7-36 sequence of GLP-1 is a potent insulin-releasing peptide in vitro [1]
The importance of SCFA-mediated GLP-1 secretion is highlighted by the observation that FFAR2 knockout mice exhibit reduced insulin levels and impaired glucose tolerance due to reduced GLP-1 levels (24)
Togame H
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis
